1-1 of 1
Esther J. H. Boey
Close
Sort by
Journal Articles

Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling

Clinical Trials & Observations
Julie R. McMullen, Esther J. H. Boey, Jenny Y. Y. Ooi, John F. Seymour, Michael J. Keating, Constantine S. Tam
Journal: Blood
Blood (2014) 124 (25): 3829–3830.
https://doi.org/10.1182/blood-2014-10-604272
Published: 2014
Includes: Supplemental data